Tag: Primary Sclerosing Cholangitis Market

Overview of the Primary Sclerosing Cholangitis Market Primary sclerosing cholangitis (PSC) is a chronic, progressive liver disorder that causes inflammation and scarring of bile ducts, potentially leading to liver failure. It has no known cure, and current treatments focus on symptom management and delaying disease progression. The increasing understanding of PSC pathophysiology, coupled with robust […]